FDA Adverse Event Injury Summary report: N

PFC SIGMARP STB TB IN 4 22.5

MDR report key: 2945107 · Received February 6, 2013

Report

Report Number
1818910-2013-11937
Event Type
Injury
Date Received
February 6, 2013
Date of Event
August 21, 2012
Report Date
January 14, 2013
Manufacturer
DEPUY IRELAND ? REG. # 9616671
Product Code
NJL
PMA / PMN Number
PP830055
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATION SINCE ITS RELEASE FOR DISTRIBUTION. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT BASED ON THE INFORMATION AVAILABLE. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

CLINICAL REPORT STATES THE PATIENT WAS REVISED BECAUSE OF INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
50404 PFC SIGMARP STB TB IN 4 22.5 TIBIAL INSERT NJL DEPUY IRELAND ? REG. # 9616671 3375113

Patients

Seq Age Sex Outcome Treatment
1 49 YR Required Intervention